Literature DB >> 17157513

Dorfin-CHIP chimeric proteins potently ubiquitylate and degrade familial ALS-related mutant SOD1 proteins and reduce their cellular toxicity.

Shinsuke Ishigaki1, Jun-ichi Niwa, Shin-ichi Yamada, Miho Takahashi, Takashi Ito, Jun Sone, Manabu Doyu, Fumihiko Urano, Gen Sobue.   

Abstract

The ubiquitin-proteasome system (UPS) is involved in the pathogenetic mechanisms of neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS). Dorfin is a ubiquitin ligase (E3) that degrades mutant SOD1 proteins, which are responsible for familial ALS. Although Dorfin has potential as an anti-ALS molecule, its life in cells is short. To improve its stability and enhance its E3 activity, we developed chimeric proteins containing the substrate-binding hydrophobic portion of Dorfin and the U-box domain of the carboxyl terminus of Hsc70-interacting protein (CHIP), which has strong E3 activity through the U-box domain. All the Dorfin-CHIP chimeric proteins were more stable in cells than was wild-type Dorfin (Dorfin(WT)). One of the Dorfin-CHIP chimeric proteins, Dorfin-CHIP(L), ubiquitylated mutant SOD1 more effectively than did Dorfin(WT) and CHIP in vivo, and degraded mutant SOD1 protein more rapidly than Dorfin(WT) does. Furthermore, Dorfin-CHIP(L) rescued neuronal cells from mutant SOD1-associated toxicity and reduced the aggresome formation induced by mutant SOD1 more effectively than did Dorfin(WT).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157513     DOI: 10.1016/j.nbd.2006.09.017

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  14 in total

Review 1.  E3 ubiquitin ligases in protein quality control mechanism.

Authors:  Deepak Chhangani; Ajay Prakash Joshi; Amit Mishra
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

Review 2.  The Emerging Roles of E3 Ligases and DUBs in Neurodegenerative Diseases.

Authors:  Na Liu; Miao-Miao Lin; Yan Wang
Journal:  Mol Neurobiol       Date:  2022-10-19       Impact factor: 5.682

3.  Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal models.

Authors:  Mohit Raja Jain; Wei-Wen Ge; Stella Elkabes; Hong Li
Journal:  Proteomics Clin Appl       Date:  2008-05-01       Impact factor: 3.494

4.  Is PROTAC technology really a game changer for central nervous system drug discovery?

Authors:  Kayla Farrell; Timothy J Jarome
Journal:  Expert Opin Drug Discov       Date:  2021-04-19       Impact factor: 7.050

5.  Phenotype and frequency of STUB1 mutations: next-generation screenings in Caucasian ataxia and spastic paraplegia cohorts.

Authors:  Matthis Synofzik; Rebecca Schüle; Martin Schulze; Janina Gburek-Augustat; Roland Schweizer; Anja Schirmacher; Ingeborg Krägeloh-Mann; Michael Gonzalez; Peter Young; Stephan Züchner; Ludger Schöls; Peter Bauer
Journal:  Orphanet J Rare Dis       Date:  2014-04-17       Impact factor: 4.123

Review 6.  The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution.

Authors:  Nico P Dantuma; Laura C Bott
Journal:  Front Mol Neurosci       Date:  2014-07-31       Impact factor: 5.639

7.  Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention.

Authors:  Aaron Carman; Sarah Kishinevsky; John Koren; Wenjie Lou; Gabriela Chiosis
Journal:  J Alzheimers Dis Parkinsonism       Date:  2013-04

8.  Identification of the ubiquitin ligase Triad1 as a regulator of endosomal transport.

Authors:  Gerco Hassink; Johan Slotman; Viola Oorschot; Bert A Van Der Reijden; Davide Monteferrario; Sylvie M Noordermeer; Peter Van Kerkhof; Judith Klumperman; Ger J Strous
Journal:  Biol Open       Date:  2012-05-09       Impact factor: 2.422

Review 9.  RBR E3 ubiquitin ligases: new structures, new insights, new questions.

Authors:  Donald E Spratt; Helen Walden; Gary S Shaw
Journal:  Biochem J       Date:  2014-03-15       Impact factor: 3.857

10.  Mice lacking the PSD-95-interacting E3 ligase, Dorfin/Rnf19a, display reduced adult neurogenesis, enhanced long-term potentiation, and impaired contextual fear conditioning.

Authors:  Hanwool Park; Jinhee Yang; Ryunhee Kim; Yan Li; Yeunkum Lee; Chungwoo Lee; Jongil Park; Dongmin Lee; Hyun Kim; Eunjoon Kim
Journal:  Sci Rep       Date:  2015-11-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.